| Product name | Semaglutide-1mg:1.5ml, 2mg:1.5ml, 4mg:3ml, 6.8mg:3ml, 9.6mg:3ml |
| Cas No.: | |
| Specification: | US FDA to be submitted; Clinical date: Phase I, Phase III (Under process) |

Cas No.:
Specification: US FDA to be submitted; Clinical date: Phase I, Phase III (Under process)
| Product name | Semaglutide-1mg:1.5ml, 2mg:1.5ml, 4mg:3ml, 6.8mg:3ml, 9.6mg:3ml |
| Cas No.: | |
| Specification: | US FDA to be submitted; Clinical date: Phase I, Phase III (Under process) |


